2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3677
  



  

  
Submitter : 
  

  
Miss. Catherine Martin
  

  
Date & Time: 
  

  
12/19/2006 09:12:46
  



  

  
Organization : 
  

  
Miss. Catherine Martin
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 As a citizen with deeply held moral principles and concern for public health, I would like to request that the FDA apply pressure upon pharmaceutical complanies to develop and implement vaccines which are not cultivated, or in any way dependent upon the cells of aborted fetuses. By pressuring pharmaceutical companies to develop alternative vaccines which are not cultivated from the cells of aborted fetuses, both the FDA and the aforesaid pharmaceutical companies will be fulfilling their moral responsibility to provide safe and effective vaccinations for all.